1095 related articles for article (PubMed ID: 18711984)
21. Prevalence of selected viral infections among blood donors deferred for potential risk to blood safety.
Zou S; Fujii K; Johnson S; Spencer B; Washington N; Iv EN; Musavi F; Newman B; Cable R; Rios J; Hillyer KL; Hillyer CD; Dodd RY;
Transfusion; 2006 Nov; 46(11):1997-2003. PubMed ID: 17076856
[TBL] [Abstract][Full Text] [Related]
22. [Prevalence of and risk factors for hepatitis C in blood donors].
Ladrón-de Guevara L; Gómez N; Vázquez-Cantarell M; García-Méndez S; Di Silvio M
Rev Gastroenterol Mex; 2002; 67(1):11-6. PubMed ID: 12066425
[TBL] [Abstract][Full Text] [Related]
23. Seroprevalence of transfusion transmissible viral infections (HIV, HBV and HCV) among voluntary blood donors at University of Gondar Comprehensive Specialized Hospital, Gondar; Northwest Ethiopia.
Tigabu A; Engda T; Mekonnen F
BMC Infect Dis; 2019 May; 19(1):393. PubMed ID: 31068138
[TBL] [Abstract][Full Text] [Related]
24. Seroprevalence of multiple sexually transmitted infections among antenatal clinic attendees in Gondar Health Center, northwest Ethiopia.
Tiruneh M
Ethiop Med J; 2008 Oct; 46(4):359-66. PubMed ID: 19271400
[TBL] [Abstract][Full Text] [Related]
25. [HIV retrospective study of the German Red Cross blood donation service in Germany].
Glück D; Elbert G; Dengler T; Gossrau E; Grässmann W; Grimm M; Holzberger G; Sternberger J; Weise W; Kubanek B
Infusionsther Transfusionsmed; 1994 Dec; 21(6):368-75. PubMed ID: 7873915
[TBL] [Abstract][Full Text] [Related]
26. Prevention of HIV transmission by blood transfusion in the developing world: achievements and continuing challenges.
Lackritz EM
AIDS; 1998; 12 Suppl A():S81-6. PubMed ID: 9632988
[TBL] [Abstract][Full Text] [Related]
27. Papua New Guinea Red Cross Blood Transfusion Service: present status and future considerations.
Tozer RA
P N G Med J; 1996 Mar; 39(1):38-42. PubMed ID: 9522849
[TBL] [Abstract][Full Text] [Related]
28. Risk of transfusion-transmitted hepatitis C virus in a tertiary hospital in Nigeria.
Imarengiaye CO; Enosolease ME; Iribhogbe PE; Ehigiegba AE
Public Health; 2006 Mar; 120(3):274-8. PubMed ID: 16364383
[TBL] [Abstract][Full Text] [Related]
29. Seroprevalency of transfusion-transmitted infections in first-time volunteer and replacement donors in Tunisia.
Ben Jemia R; Gouider E
Transfus Clin Biol; 2014 Dec; 21(6):303-8. PubMed ID: 25458983
[TBL] [Abstract][Full Text] [Related]
30. Residual risk of transfusion-transmitted viral infections in Shenzhen, China, 2001 through 2004.
Shang G; Seed CR; Wang F; Nie D; Farrugia A
Transfusion; 2007 Mar; 47(3):529-39. PubMed ID: 17319836
[TBL] [Abstract][Full Text] [Related]
31. Markers for transfusion-associated hepatitis in north Indian blood donors: prevalence and trends.
Singh B; Verma M; Verma K
Jpn J Infect Dis; 2004 Apr; 57(2):49-51. PubMed ID: 15118208
[TBL] [Abstract][Full Text] [Related]
32. Trends in transfusion-transmissible infections among Australian blood donors from 2005 to 2010.
Lucky TT; Seed CR; Keller A; Lee J; McDonald A; Ismay S; Wand H; Wilson DP
Transfusion; 2013 Nov; 53(11):2751-62. PubMed ID: 23461827
[TBL] [Abstract][Full Text] [Related]
33. Dengue virus in blood donations, Puerto Rico, 2005.
Mohammed H; Linnen JM; Muñoz-Jordán JL; Tomashek K; Foster G; Broulik AS; Petersen L; Stramer SL
Transfusion; 2008 Jul; 48(7):1348-54. PubMed ID: 18503611
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of transmissible blood infections among blood donors at the University of Maiducuri Teaching Hospital, Maiduguri, Nigeria.
Chikwem JO; Mohammed I; Okara GC; Ukwandu NC; Ola TO
East Afr Med J; 1997 Apr; 74(4):213-6. PubMed ID: 9299819
[TBL] [Abstract][Full Text] [Related]
35. Reducing the risk of HIV transmission through blood transfusion by donor self-deferral.
Urwijitaroon Y; Barusrux S; Romphruk A; Puapairoj C; Pakote L
Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):452-6. PubMed ID: 9185252
[TBL] [Abstract][Full Text] [Related]
36. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
37. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
38. Prevalence of markers of transfusion transmissible diseases in voluntary and replacement blood donors.
Sharma RR; Cheema R; Vajpayee M; Rao U; Kumar S; Marwaha N; Agnihotri SK
Natl Med J India; 2004; 17(1):19-21. PubMed ID: 15115227
[TBL] [Abstract][Full Text] [Related]
39. [Blood transfusion in Ethiopia].
Massenet D; Tesfaye G; Dandera B
Med Trop (Mars); 1998; 58(3):307-8. PubMed ID: 10088111
[TBL] [Abstract][Full Text] [Related]
40. [A retrospective study of the practice of "look-back" procedures, on the incidence of HIV-1/2-positive blood donors and the risk of transfusion-associated HIV infection in public-community blood banks in Germany].
Zeiler T; Kretschmer V; Sibrowski W
Infusionsther Transfusionsmed; 1994 Dec; 21(6):362-7. PubMed ID: 7873914
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
